Literature DB >> 1464762

Neural regulation of N-cadherin gene expression in developing and adult skeletal muscle.

C G Hahn1, J Covault.   

Abstract

Using monoclonal antibody and cDNA probes, we have studied N-cadherin gene expression in developing and adult chick skeletal muscle. N-cadherin was expressed by developing myotubes during the period of initial nerve-muscle contact but was downregulated within days of innervation. Treatment of embryos with d-tubocurare partially reversed this downregulation. In the adult, there were muscle fiber type differences in N-cadherin expression. N-cadherin was undetectable on normally innervated twitch fibers, while multiply innervated tonic muscle fibers expressed low but readily detectable levels of N-cadherin. Denervation led to the renewed expression of N-cadherin in twitch fibers as well as a marked increase in expression in tonic fibers. Levels of N-cadherin expressed by tonic fibers could also be modulated by animal housing conditions that favored either increased or decreased levels of daily motor activity. Increased motor activity was correlated with decreased levels of N-cadherin, while decreased motor activity correlated with increased levels of muscle N-cadherin. Results of in vitro studies using the calcium channel agonist ryanodine suggest that changes in intracellular calcium may be the initial signal linking neural stimulation with changes in muscle fiber expression of N-cadherin. Together, our results indicate that neural stimulation of chick skeletal muscle fibers dynamically and reversibly downregulates the expression of N-cadherin mRNA and protein. This pattern of regulation may be functionally important in limiting and/or promoting axon growth in innervated versus denervated muscle and may serve as a molecular model system for studies of the activity-dependent regulation of gene expression.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1464762      PMCID: PMC6575763     

Source DB:  PubMed          Journal:  J Neurosci        ISSN: 0270-6474            Impact factor:   6.167


  8 in total

1.  E- and N-cadherin distribution in developing and functional human teeth under normal and pathological conditions.

Authors:  Robert Heymann; Imad About; Urban Lendahl; Jean-Claude Franquin; Björn Obrink; Thimios A Mitsiadis
Journal:  Am J Pathol       Date:  2002-06       Impact factor: 4.307

2.  Normal myoblast fusion requires myoferlin.

Authors:  Katherine R Doherty; Andrew Cave; Dawn Belt Davis; Anthony J Delmonte; Avery Posey; Judy U Earley; Michele Hadhazy; Elizabeth M McNally
Journal:  Development       Date:  2005-11-09       Impact factor: 6.868

3.  AML1 is expressed in skeletal muscle and is regulated by innervation.

Authors:  X Zhu; J E Yeadon; S J Burden
Journal:  Mol Cell Biol       Date:  1994-12       Impact factor: 4.272

4.  Effects of age on aneural regeneration of soleus muscle in rat.

Authors:  D M Lewis; H Schmalbruch
Journal:  J Physiol       Date:  1995-10-15       Impact factor: 5.182

5.  Contractile activity regulates isoform expression and polysialylation of NCAM in cultured myotubes: involvement of Ca2+ and protein kinase C.

Authors:  V F Rafuse; L Landmesser
Journal:  J Cell Biol       Date:  1996-03       Impact factor: 10.539

6.  Repression of slow myosin heavy chain 2 gene expression in fast skeletal muscle fibers by muscarinic acetylcholine receptor and G(alpha)q signaling.

Authors:  Theresa Jordan; Jinyuan Li; Hongbin Jiang; Joseph X DiMario
Journal:  J Cell Biol       Date:  2003-09-01       Impact factor: 10.539

7.  Altered secondary myogenesis in transgenic animals expressing the neural cell adhesion molecule under the control of a skeletal muscle alpha-actin promoter.

Authors:  S Fazeli; D J Wells; C Hobbs; F S Walsh
Journal:  J Cell Biol       Date:  1996-10       Impact factor: 10.539

8.  Regulation and activity-dependence of N-cadherin, NCAM isoforms, and polysialic acid on chick myotubes during development.

Authors:  B Fredette; U Rutishauser; L Landmesser
Journal:  J Cell Biol       Date:  1993-12       Impact factor: 10.539

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.